Skip to main content
Top
Published in: Current Neurology and Neuroscience Reports 5/2015

01-05-2015 | Sleep (M Thorpy, M Billiard, Section Editors)

Sleep Disorders in Multiple Sclerosis. Review

Author: Christian Veauthier

Published in: Current Neurology and Neuroscience Reports | Issue 5/2015

Login to get access

Abstract

Sleep disorders are common in patients with multiple sclerosis (MS) and play a crucial role in health and quality of life; however, they are often overlooked. The most important sleep disorders in this context are as follows: insomnia, restless legs syndrome, periodic limb movement disorders, and sleep-related breathing disorders (SRBD). It is unclear if MS-related processes (lesions, brain atrophy) can cause symptomatic forms of sleep apnea. MS-related narcolepsy-like symptoms are described in the literature and, in some cases, have resolved with methylprednisolone pulse therapy. Similarly, REM sleep behavior disorder (RBD) is very rare in MS, but it can be an initial sign of MS where cortisone therapy may be helpful and can be taken into account in this specific context. Independent diagnosis and treatment is required for all of the abovementioned conditions. Treating physicians and neurologists should be aware of these comorbidities and initiate specific therapy. Highly fatigued or sleepy MS patients should have polysomnography in order not to overlook these diagnoses.
Literature
2.
go back to reference Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med. 1998;338:278–85.CrossRefPubMed Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med. 1998;338:278–85.CrossRefPubMed
3.
go back to reference Farez MF, Balbuena Aguirre ME, Varela F, Köhler AA, Correale J. Autoimmune disease prevalence in a multiple sclerosis cohort in Argentina. Mult Scler Int. 2014;828162. doi: 10.1155/2014/828162. Farez MF, Balbuena Aguirre ME, Varela F, Köhler AA, Correale J. Autoimmune disease prevalence in a multiple sclerosis cohort in Argentina. Mult Scler Int. 2014;828162. doi: 10.​1155/​2014/​828162.
5.
go back to reference World Health Organization. Atlas multiple sclerosis resources in the world 2008. Geneva: WHO Press; 2008. World Health Organization. Atlas multiple sclerosis resources in the world 2008. Geneva: WHO Press; 2008.
6.
go back to reference Evans C, Beland SG, Kulaga S, Wolfson C, Kingwell E, Marriott J, et al. Incidence and prevalence of multiple sclerosis in the Americas: a systematic review. Neuroepidemiology. 2013;40(3):195–210. doi:10.1159/000342779.CrossRefPubMed Evans C, Beland SG, Kulaga S, Wolfson C, Kingwell E, Marriott J, et al. Incidence and prevalence of multiple sclerosis in the Americas: a systematic review. Neuroepidemiology. 2013;40(3):195–210. doi:10.​1159/​000342779.CrossRefPubMed
7.
go back to reference Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328(17):1230–5.CrossRefPubMed Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328(17):1230–5.CrossRefPubMed
8.
go back to reference Berger K, Luedemann J, Trenkwalder C, John U, Kessler C. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med. 2004;164(2):196–202.CrossRefPubMed Berger K, Luedemann J, Trenkwalder C, John U, Kessler C. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med. 2004;164(2):196–202.CrossRefPubMed
9.
go back to reference Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6:97–111.CrossRefPubMed Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6:97–111.CrossRefPubMed
10.
go back to reference Manconi M, Ferini-Strambi L, Filippi M, Bonanni E, Iudice A, Murri L, et al. Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS Study. Sleep. 2008;31:944–52.PubMedCentralPubMed Manconi M, Ferini-Strambi L, Filippi M, Bonanni E, Iudice A, Murri L, et al. Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS Study. Sleep. 2008;31:944–52.PubMedCentralPubMed
11.
go back to reference Nishino S, Kanbayashi T. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Med Rev. 2005;9(4):269–310.CrossRefPubMed Nishino S, Kanbayashi T. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Med Rev. 2005;9(4):269–310.CrossRefPubMed
12.
go back to reference Veauthier C, Radbruch H, Gaede G, Pfueller CF, Dörr J, Bellmann-Strobl J, et al. Fatigue in multiple sclerosis is closely related to sleep disorders: a polysomnographic cross-sectional study. Mult Scler. 2011;17(5):613–22. doi:10.1177/1352458510393772.CrossRefPubMed Veauthier C, Radbruch H, Gaede G, Pfueller CF, Dörr J, Bellmann-Strobl J, et al. Fatigue in multiple sclerosis is closely related to sleep disorders: a polysomnographic cross-sectional study. Mult Scler. 2011;17(5):613–22. doi:10.​1177/​1352458510393772​.CrossRefPubMed
13.•
go back to reference American Academy of Sleep Medicine. International Classification of Sleep Disorders, 3rd ed: Diagnostic and Coding Manual. Darien: American Academy of Sleep Medicine; 2014. The third revision (ICSD-3) is the authoritative clinical text for the diagnosis and treatment of sleep disorders and an essential reference for all clinicians treating patients with sleep disorders. The third revision shows significant content changes, including new nomenclature, classifications and diagnoses. American Academy of Sleep Medicine. International Classification of Sleep Disorders, 3rd ed: Diagnostic and Coding Manual. Darien: American Academy of Sleep Medicine; 2014. The third revision (ICSD-3) is the authoritative clinical text for the diagnosis and treatment of sleep disorders and an essential reference for all clinicians treating patients with sleep disorders. The third revision shows significant content changes, including new nomenclature, classifications and diagnoses.
16.
go back to reference Guilleminault C, Lopes MC, Hagen CC, da Rosa A. The cyclic alternating pattern demonstrates increased sleep instability and correlates with fatigue and sleepiness in adults with upper airway resistance syndrome. Sleep. 2007;30(5):641–7.PubMed Guilleminault C, Lopes MC, Hagen CC, da Rosa A. The cyclic alternating pattern demonstrates increased sleep instability and correlates with fatigue and sleepiness in adults with upper airway resistance syndrome. Sleep. 2007;30(5):641–7.PubMed
17.
go back to reference Guilleminault C, Stoohs R, Clerk A, Simmons J, Labanowski M. From obstructive sleep apnea syndrome to upper airway resistance syndrome: consistency of daytime sleepiness. Sleep. 1992;15(6 Suppl):S13–6.PubMed Guilleminault C, Stoohs R, Clerk A, Simmons J, Labanowski M. From obstructive sleep apnea syndrome to upper airway resistance syndrome: consistency of daytime sleepiness. Sleep. 1992;15(6 Suppl):S13–6.PubMed
18.•
go back to reference Veauthier C, Paul F. Sleep disorders in multiple sclerosis and their relationship to fatigue. Sleep Med. 2014;15(1):5–14. doi:10.1016/j.sleep.2013.08.791. This recently published review highlights the relationship between MS related fatigue and sleep disorders and summarizes in particular the studies investigating insomnia in MS patients.CrossRefPubMed Veauthier C, Paul F. Sleep disorders in multiple sclerosis and their relationship to fatigue. Sleep Med. 2014;15(1):5–14. doi:10.​1016/​j.​sleep.​2013.​08.​791. This recently published review highlights the relationship between MS related fatigue and sleep disorders and summarizes in particular the studies investigating insomnia in MS patients.CrossRefPubMed
20.
go back to reference Iber C, Ancoli-Israel S, Chesson Jr AL. American Academy of Sleep Medicine. The AASM Manual for the scoring of sleep and associated events: rules, terminology and technical specifications. Westchester: American Academy of Sleep Medicine; 2007. Iber C, Ancoli-Israel S, Chesson Jr AL. American Academy of Sleep Medicine. The AASM Manual for the scoring of sleep and associated events: rules, terminology and technical specifications. Westchester: American Academy of Sleep Medicine; 2007.
21.
go back to reference American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep. 1999;22:667–89. American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep. 1999;22:667–89.
24.
go back to reference Kallweit U, Baumann CR, Harzheim M, Hidalgo H, Pöhlau D, Bassetti CL, et al. Fatigue and sleep-disordered breathing in multiple sclerosis: a clinically relevant association? Mult Scler Int. 2013;2013:286581. doi:10.1155/2013/286581.PubMedCentralPubMed Kallweit U, Baumann CR, Harzheim M, Hidalgo H, Pöhlau D, Bassetti CL, et al. Fatigue and sleep-disordered breathing in multiple sclerosis: a clinically relevant association? Mult Scler Int. 2013;2013:286581. doi:10.​1155/​2013/​286581.PubMedCentralPubMed
25.
go back to reference Braley TJ, Chervin RD, Segal BM. Fatigue, tiredness, lack of energy, and sleepiness in multiple sclerosis patients referred for clinical polysomnography. Mult Scler Int. 2012:673936. doi: 10.1155/2012/673936. Braley TJ, Chervin RD, Segal BM. Fatigue, tiredness, lack of energy, and sleepiness in multiple sclerosis patients referred for clinical polysomnography. Mult Scler Int. 2012:673936. doi: 10.​1155/​2012/​673936.
27.•
go back to reference Veauthier C, Paul F. Fatigue in multiple sclerosis: which patient should be referred to a sleep specialist? Mult Scler. 2012;18(2):248–9. doi:10.1177/1352458511411229. For clinicians it is difficult to decide which patient should be admitted to a sleep laboratory for polysomnographic analyzes. The authors analyzed retrospectively their data of the first cross-sectional polysomnographic trial in order to find out a screening instrument.CrossRefPubMed Veauthier C, Paul F. Fatigue in multiple sclerosis: which patient should be referred to a sleep specialist? Mult Scler. 2012;18(2):248–9. doi:10.​1177/​1352458511411229​. For clinicians it is difficult to decide which patient should be admitted to a sleep laboratory for polysomnographic analyzes. The authors analyzed retrospectively their data of the first cross-sectional polysomnographic trial in order to find out a screening instrument.CrossRefPubMed
28.
go back to reference Multiple Sclerosis Council for Clinical Practice Guidelines. Fatigue and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis. Washington, DC: Paralyzed Veterans of America; 1998. Multiple Sclerosis Council for Clinical Practice Guidelines. Fatigue and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis. Washington, DC: Paralyzed Veterans of America; 1998.
29.
go back to reference Flachenecker P, Kümpfel T, Kallmann B, Gottschalk M, Grauer O, Rieckmann P, et al. Fatigue in multiple sclerosis: a comparison of different rating scales. Mult Scler. 2002;8:523–6.CrossRefPubMed Flachenecker P, Kümpfel T, Kallmann B, Gottschalk M, Grauer O, Rieckmann P, et al. Fatigue in multiple sclerosis: a comparison of different rating scales. Mult Scler. 2002;8:523–6.CrossRefPubMed
30.
go back to reference Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213.CrossRefPubMed Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213.CrossRefPubMed
32.
go back to reference Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Los Angeles: Brain Information Service/Brain Research Institute, UCLA; 1968. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Los Angeles: Brain Information Service/Brain Research Institute, UCLA; 1968.
33.
go back to reference Lichstein KL, Means MK, Noe SL, Aguillard RN. Fatigue and sleep disorders. Behav Res Ther. 1997;35:733–40.CrossRefPubMed Lichstein KL, Means MK, Noe SL, Aguillard RN. Fatigue and sleep disorders. Behav Res Ther. 1997;35:733–40.CrossRefPubMed
34.
go back to reference Bardwell WA, Moore P, Ancoli-Israel S, Dimsdale JE. Fatigue in obstructive sleep apnea: driven by depressive symptoms instead of apnea severity? Am J Psychiatry. 2003;160:350–5.CrossRefPubMed Bardwell WA, Moore P, Ancoli-Israel S, Dimsdale JE. Fatigue in obstructive sleep apnea: driven by depressive symptoms instead of apnea severity? Am J Psychiatry. 2003;160:350–5.CrossRefPubMed
35.
go back to reference American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington DC: American Psychiatric Association; 1994. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington DC: American Psychiatric Association; 1994.
36.
go back to reference World Health Organization. The ICD-10 classification of mental and behavioural disorders. Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization; 1992. World Health Organization. The ICD-10 classification of mental and behavioural disorders. Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization; 1992.
38.
go back to reference Leonavicius R, Adomaitiene V. Features of sleep disturbances in multiple sclerosis patients. Psychiatr Danub. 2014;26(3):249–55.PubMed Leonavicius R, Adomaitiene V. Features of sleep disturbances in multiple sclerosis patients. Psychiatr Danub. 2014;26(3):249–55.PubMed
39.
go back to reference Hays R, Stewart A. Sleep measures. In: Stewart A, Ware J, editors. Measuring functioning and well-being: the medical outcomes study approach. Durham: Duke University Press; 1992. p. 235–9. Hays R, Stewart A. Sleep measures. In: Stewart A, Ware J, editors. Measuring functioning and well-being: the medical outcomes study approach. Durham: Duke University Press; 1992. p. 235–9.
40.
go back to reference Tachibana N, Howard RS, Hirsch NP, et al. Sleep problems in multiple sclerosis. Eur Neurol. 1994;34:320–3.CrossRefPubMed Tachibana N, Howard RS, Hirsch NP, et al. Sleep problems in multiple sclerosis. Eur Neurol. 1994;34:320–3.CrossRefPubMed
41.
go back to reference Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;4(5):487–504.PubMedCentralPubMed Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;4(5):487–504.PubMedCentralPubMed
42.
go back to reference Dauvilliers Y, Winkelmann J. Restless legs syndrome: update on pathogenesis. Curr Opin Pulm Med. 2013;19(6):594–600.CrossRefPubMed Dauvilliers Y, Winkelmann J. Restless legs syndrome: update on pathogenesis. Curr Opin Pulm Med. 2013;19(6):594–600.CrossRefPubMed
43.
go back to reference Winkelmann J, Schormair B, Lichtner P, et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet. 2007;39(8):1000–6.CrossRefPubMed Winkelmann J, Schormair B, Lichtner P, et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet. 2007;39(8):1000–6.CrossRefPubMed
44.
go back to reference Winkelman JW. Periodic limb movements in sleep―endophenotype for restless legs syndrome? N Engl J Med. 2007;357(7):703–5. Winkelman JW. Periodic limb movements in sleep―endophenotype for restless legs syndrome? N Engl J Med. 2007;357(7):703–5.
45.•
go back to reference Aurora RN, Kristo DA, Bista SR, et al. The treatment of restless legs syndrome and periodic limb movement disorder in adults-an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline. Sleep. 2012;35:1039–62. This study summarizes recently performed treatment studies in the field of periodic limb movement disorder (PLMD) and restless legs syndrome (RLS) and can be considered as the actual guideline of the treatment of these two disorders.PubMedCentralPubMed Aurora RN, Kristo DA, Bista SR, et al. The treatment of restless legs syndrome and periodic limb movement disorder in adults-an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline. Sleep. 2012;35:1039–62. This study summarizes recently performed treatment studies in the field of periodic limb movement disorder (PLMD) and restless legs syndrome (RLS) and can be considered as the actual guideline of the treatment of these two disorders.PubMedCentralPubMed
47.•
go back to reference Cho YW, Allen RP, Earley CJ. Lower molecular weight intravenous iron dextran for restless legs syndrome. Sleep Med. 2013;14(3):274–7. doi:10.1016/j.sleep.2012.11.001. Iron therapy is underestimated in the treatment of RLS and it is important to point out, that this therapy can improve RLS and should not be forgotten.CrossRefPubMed Cho YW, Allen RP, Earley CJ. Lower molecular weight intravenous iron dextran for restless legs syndrome. Sleep Med. 2013;14(3):274–7. doi:10.​1016/​j.​sleep.​2012.​11.​001. Iron therapy is underestimated in the treatment of RLS and it is important to point out, that this therapy can improve RLS and should not be forgotten.CrossRefPubMed
48.
50.
go back to reference Sansa G, Iranzo A, Santamaria J. Obstructive sleep apnea in narcolepsy. Sleep Med. 2010;11(1):93–5.CrossRefPubMed Sansa G, Iranzo A, Santamaria J. Obstructive sleep apnea in narcolepsy. Sleep Med. 2010;11(1):93–5.CrossRefPubMed
51.
go back to reference Knudsen S, Gammeltoft S, Jennum PJ. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency. Brain. 2010;133(Pt 2):568–79.CrossRefPubMed Knudsen S, Gammeltoft S, Jennum PJ. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency. Brain. 2010;133(Pt 2):568–79.CrossRefPubMed
52.
go back to reference Schenck CH, Mahowald MW. Motor dyscontrol in narcolepsy: rapid-eye-movement (REM) sleep without atonia and REM sleep behavior disorder. Ann Neurol. 1992;32(1):3–10.CrossRefPubMed Schenck CH, Mahowald MW. Motor dyscontrol in narcolepsy: rapid-eye-movement (REM) sleep without atonia and REM sleep behavior disorder. Ann Neurol. 1992;32(1):3–10.CrossRefPubMed
53.
go back to reference Schenck CH, Hurwitz TD, Bundlie SR, Mahowald MW. Sleep-related eating disorders: polysomnographic correlates of a heterogeneous syndrome distinct from daytime eating disorders. Sleep. 1991;14(5):419–31.PubMed Schenck CH, Hurwitz TD, Bundlie SR, Mahowald MW. Sleep-related eating disorders: polysomnographic correlates of a heterogeneous syndrome distinct from daytime eating disorders. Sleep. 1991;14(5):419–31.PubMed
54.
go back to reference Longstreth Jr WT, Koepsell TD, Ton TG, Hendrickson AF, van Belle G. The epidemiology of narcolepsy. Sleep. 2007;30(1):13–26.PubMed Longstreth Jr WT, Koepsell TD, Ton TG, Hendrickson AF, van Belle G. The epidemiology of narcolepsy. Sleep. 2007;30(1):13–26.PubMed
55.
go back to reference Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998;92(4):573–85.CrossRefPubMed Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998;92(4):573–85.CrossRefPubMed
56.
go back to reference De Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, et al. The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A. 1998;95(1):322–7.CrossRefPubMedCentralPubMed De Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, et al. The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A. 1998;95(1):322–7.CrossRefPubMedCentralPubMed
57.
go back to reference Preedy VR, Watson RR, Martin CR. Handbook of behavior, food and nutrition. New York: Springer; 2011.CrossRef Preedy VR, Watson RR, Martin CR. Handbook of behavior, food and nutrition. New York: Springer; 2011.CrossRef
58.
go back to reference Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, Yanagisawa M, et al. Differential expression of orexin receptors 1 and 2 in the rat brain. J Compt Neurol. 2001;435(1):6–25.CrossRef Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, Yanagisawa M, et al. Differential expression of orexin receptors 1 and 2 in the rat brain. J Compt Neurol. 2001;435(1):6–25.CrossRef
59.
go back to reference Berg O, Hanley J. Narcolepsy in two cases of multiple sclerosis. Acta Neurol Scand. 1963;39:252–6.CrossRefPubMed Berg O, Hanley J. Narcolepsy in two cases of multiple sclerosis. Acta Neurol Scand. 1963;39:252–6.CrossRefPubMed
60.
61.
go back to reference Schrader H, Gotlibsen OB, Skomedal GN. Multiple sclerosis and narcolepsy/cataplexy in a monozygotic twin. Neurology. 1980;30(1):105–8.CrossRefPubMed Schrader H, Gotlibsen OB, Skomedal GN. Multiple sclerosis and narcolepsy/cataplexy in a monozygotic twin. Neurology. 1980;30(1):105–8.CrossRefPubMed
62.
go back to reference Younger DS, Pedley TA, Thorpy MJ. Multiple sclerosis and narcolepsy: possible similar genetic susceptibility. Neurology. 1991;41(3):447–8.CrossRefPubMed Younger DS, Pedley TA, Thorpy MJ. Multiple sclerosis and narcolepsy: possible similar genetic susceptibility. Neurology. 1991;41(3):447–8.CrossRefPubMed
63.
go back to reference Wang CY, Kawashima H, Takami T, Yamada N, Miyajima T, Ogihara M, et al. [A case of multiple sclerosis with initial symptoms of narcolepsy]. [Article in Japanese]. No To Hattatsu. 1998;30(4):300–6.PubMed Wang CY, Kawashima H, Takami T, Yamada N, Miyajima T, Ogihara M, et al. [A case of multiple sclerosis with initial symptoms of narcolepsy]. [Article in Japanese]. No To Hattatsu. 1998;30(4):300–6.PubMed
64.
go back to reference Iseki K, Mezaki T, Oka Y, Terada K, Tomimoto H, Miki Y, et al. Hypersomnia in MS. Neurology. 2002;59(12):2006–7.CrossRefPubMed Iseki K, Mezaki T, Oka Y, Terada K, Tomimoto H, Miki Y, et al. Hypersomnia in MS. Neurology. 2002;59(12):2006–7.CrossRefPubMed
65.
go back to reference Oka Y, Kanbayashi T, Mezaki T, Iseki K, Matsubayashi J, Murakami G, et al. Low CSF hypocretin-1/orexin-A associated with hypersomnia secondary to hypothalamic lesion in a case of multiple sclerosis. J Neurol. 2004;251(7):885–6.CrossRefPubMed Oka Y, Kanbayashi T, Mezaki T, Iseki K, Matsubayashi J, Murakami G, et al. Low CSF hypocretin-1/orexin-A associated with hypersomnia secondary to hypothalamic lesion in a case of multiple sclerosis. J Neurol. 2004;251(7):885–6.CrossRefPubMed
66.
go back to reference Kato T, Kanbayashi T, Yamamoto K, Nakano T, Shimizu T, Hashimoto T, et al. Hypersomnia and low CSF hypocretin-1 (orexin-A) concentration in a patient with multiple sclerosis showing bilateral hypothalamic lesions. Intern Med. 2003;42(8):743–5.CrossRefPubMed Kato T, Kanbayashi T, Yamamoto K, Nakano T, Shimizu T, Hashimoto T, et al. Hypersomnia and low CSF hypocretin-1 (orexin-A) concentration in a patient with multiple sclerosis showing bilateral hypothalamic lesions. Intern Med. 2003;42(8):743–5.CrossRefPubMed
68.
go back to reference Vrethem M, Malmgren K, Lindh J. A patient with both narcolepsy and multiple sclerosis in association with Pandemrix vaccination. J Neurol Sci. 2012;321(1–2):89–91.CrossRefPubMed Vrethem M, Malmgren K, Lindh J. A patient with both narcolepsy and multiple sclerosis in association with Pandemrix vaccination. J Neurol Sci. 2012;321(1–2):89–91.CrossRefPubMed
69.
go back to reference Peraita-Adrados R, Lammers GJ, De Andrés C, Santamaría J, Vicario JL, Tafti M. A patient with narcolepsy with cataplexy and multiple sclerosis: two different diseases that may share pathophysiologic mechanisms? Sleep Med. 2013;14(7):695–6. doi:10.1016/j.sleep.2013.03.015. Epub 2013 May 18.CrossRefPubMed Peraita-Adrados R, Lammers GJ, De Andrés C, Santamaría J, Vicario JL, Tafti M. A patient with narcolepsy with cataplexy and multiple sclerosis: two different diseases that may share pathophysiologic mechanisms? Sleep Med. 2013;14(7):695–6. doi:10.​1016/​j.​sleep.​2013.​03.​015. Epub 2013 May 18.CrossRefPubMed
70.
go back to reference Martínez-Orozco FJ, Vicario JL, Villalibre-Valderrey I, De Andrés C, Fernández-Arquero M, Peraita-Adrados R. Narcolepsy with cataplexy and comorbid immunopathological diseases. J Sleep Res. 2014;23(4):414–9. doi:10.1111/jsr.12143. Epub 2014 Mar 20.CrossRefPubMed Martínez-Orozco FJ, Vicario JL, Villalibre-Valderrey I, De Andrés C, Fernández-Arquero M, Peraita-Adrados R. Narcolepsy with cataplexy and comorbid immunopathological diseases. J Sleep Res. 2014;23(4):414–9. doi:10.​1111/​jsr.​12143. Epub 2014 Mar 20.CrossRefPubMed
71.
go back to reference Jacobsohn E. Ein Fall von Narkolepsie. Klin Wochenschrift. 1926;2:2188. Jacobsohn E. Ein Fall von Narkolepsie. Klin Wochenschrift. 1926;2:2188.
72.
go back to reference Heyck H, Hess R. Some results of clinical studies on narcolepsy. Schweiz Arch Neurol Psychiatr. 1955;75(1–2):401–2.PubMed Heyck H, Hess R. Some results of clinical studies on narcolepsy. Schweiz Arch Neurol Psychiatr. 1955;75(1–2):401–2.PubMed
73.
go back to reference Dauvilliers. CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions. J Neurol Neurosurg Psychiatry. 2003;74(12):1667–73.CrossRefPubMedCentralPubMed Dauvilliers. CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions. J Neurol Neurosurg Psychiatry. 2003;74(12):1667–73.CrossRefPubMedCentralPubMed
76.
go back to reference Bontadini A. HLA techniques: typing and antibody detection in the laboratory of immunogenetics. Methods. 2012;56(4):471–6.CrossRefPubMed Bontadini A. HLA techniques: typing and antibody detection in the laboratory of immunogenetics. Methods. 2012;56(4):471–6.CrossRefPubMed
77.
go back to reference Rubio JP, Bahlo M, Stankovich J, Burfoot RK, Johnson LJ, Huxtable S, et al. Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients. Immunogenetics. 2007;59(3):177–86.CrossRefPubMed Rubio JP, Bahlo M, Stankovich J, Burfoot RK, Johnson LJ, Huxtable S, et al. Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients. Immunogenetics. 2007;59(3):177–86.CrossRefPubMed
78.
go back to reference Watson NF, Ton TG, Koepsell TD, Gersuk VH, Longstreth Jr WT. Does narcolepsy symptom severity vary according to HLA-DQB1*0602 allele status? Sleep. 2010;33(1):29–35.PubMedCentralPubMed Watson NF, Ton TG, Koepsell TD, Gersuk VH, Longstreth Jr WT. Does narcolepsy symptom severity vary according to HLA-DQB1*0602 allele status? Sleep. 2010;33(1):29–35.PubMedCentralPubMed
79.
go back to reference van der Heide A, Verduijn W, Haasnoot GW, Drabbels JJ, Lammers GJ, Claas FH. HLA dosage effect in narcolepsy with cataplexy. Immunogenetics. 2014. van der Heide A, Verduijn W, Haasnoot GW, Drabbels JJ, Lammers GJ, Claas FH. HLA dosage effect in narcolepsy with cataplexy. Immunogenetics. 2014.
80.•
go back to reference Han F, Lin L, Schormair B, Pizza F, Plazzi G, Ollila HM, et al. HLA DQB1*06:02 negative narcolepsy with hypocretin/orexin deficiency. Sleep. 2014;37(10):1601–8. doi:10.5665/sleep.4066. There are only few HLA DQB1*06:02 negative patients suffering from narcolepsy with cataplexy and hypocretin deficiency. This recently published article suggests a possible secondary association in these cases with HLA-DP.PubMedCentralPubMed Han F, Lin L, Schormair B, Pizza F, Plazzi G, Ollila HM, et al. HLA DQB1*06:02 negative narcolepsy with hypocretin/orexin deficiency. Sleep. 2014;37(10):1601–8. doi:10.​5665/​sleep.​4066. There are only few HLA DQB1*06:02 negative patients suffering from narcolepsy with cataplexy and hypocretin deficiency. This recently published article suggests a possible secondary association in these cases with HLA-DP.PubMedCentralPubMed
81.
go back to reference Poirier G, Montplaisir J, Dumont M, Duquette P, Décary F, Pleines J, et al. Clinical and sleep laboratory study of narcoleptic symptoms in multiple sclerosis. Neurology. 1987;37(4):693–5.CrossRefPubMed Poirier G, Montplaisir J, Dumont M, Duquette P, Décary F, Pleines J, et al. Clinical and sleep laboratory study of narcoleptic symptoms in multiple sclerosis. Neurology. 1987;37(4):693–5.CrossRefPubMed
82.
go back to reference Kaynak H, Altintas A, Kaynak D, Uyanik O, Saip S, Ağaoğlu J, et al. Fatigue and sleep disturbance in multiple sclerosis. Eur J Neurol. 2006;13:1333–9.CrossRefPubMed Kaynak H, Altintas A, Kaynak D, Uyanik O, Saip S, Ağaoğlu J, et al. Fatigue and sleep disturbance in multiple sclerosis. Eur J Neurol. 2006;13:1333–9.CrossRefPubMed
83.
go back to reference Neau JP, Paquereau J, Auche V, Mathis S, Godeneche G, Ciron J, et al. Sleep disorders and multiple sclerosis: a clinical and polysomnography study. Eur Neurol. 2012;68(1):8–15. doi:10.1159/000335076.CrossRefPubMed Neau JP, Paquereau J, Auche V, Mathis S, Godeneche G, Ciron J, et al. Sleep disorders and multiple sclerosis: a clinical and polysomnography study. Eur Neurol. 2012;68(1):8–15. doi:10.​1159/​000335076.CrossRefPubMed
84.
go back to reference Huitinga I, Erkut Z, van Beurden D, Swaab DF. The hypothalamo-pituitary-adrenal axis in multiple sclerosis. Ann NY Acad Sci. 2003;992:118–28.CrossRefPubMed Huitinga I, Erkut Z, van Beurden D, Swaab DF. The hypothalamo-pituitary-adrenal axis in multiple sclerosis. Ann NY Acad Sci. 2003;992:118–28.CrossRefPubMed
85.
go back to reference Plazzi G, Montagna P. Remitting REM sleep behaviour disorder as the initial sign of multiple sclerosis. Sleep Med. 2002;3:437–9.CrossRefPubMed Plazzi G, Montagna P. Remitting REM sleep behaviour disorder as the initial sign of multiple sclerosis. Sleep Med. 2002;3:437–9.CrossRefPubMed
86.
go back to reference Tippmann-Peikert M, Boeve BF, Keegan BM. REM sleep behavior disorder initiated by acute brainstem multiple sclerosis. Neurology. 2006;66(8):1277–9.CrossRefPubMed Tippmann-Peikert M, Boeve BF, Keegan BM. REM sleep behavior disorder initiated by acute brainstem multiple sclerosis. Neurology. 2006;66(8):1277–9.CrossRefPubMed
87.
go back to reference Gómez-Choco MJ, Iranzo A, Blanco Y, et al. Prevalence of restless legs syndrome and REM sleep behavior disorder in multiple sclerosis. Mult Scler. 2007;13:805–8.CrossRefPubMed Gómez-Choco MJ, Iranzo A, Blanco Y, et al. Prevalence of restless legs syndrome and REM sleep behavior disorder in multiple sclerosis. Mult Scler. 2007;13:805–8.CrossRefPubMed
Metadata
Title
Sleep Disorders in Multiple Sclerosis. Review
Author
Christian Veauthier
Publication date
01-05-2015
Publisher
Springer US
Published in
Current Neurology and Neuroscience Reports / Issue 5/2015
Print ISSN: 1528-4042
Electronic ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-015-0546-0

Other articles of this Issue 5/2015

Current Neurology and Neuroscience Reports 5/2015 Go to the issue

Headache (RB Halker, Section Editor)

CGRP Mechanism Antagonists and Migraine Management

Stroke (HP Adams, Section Editor)

Development of Regional Stroke Programs

Movement Disorders (M Okun, Section Editor)

The Prion Hypothesis of Parkinson’s Disease

Pediatric Neurology (P Pearl, Section Editor)

Glutamate and GABA Imbalance Following Traumatic Brain Injury